News
Burrill & Company Leads $12.9 Million Series E Round In WhiteGlove Health April 16, 2012 | Press Release
Burrill & Company Leads $16.5 Million Round in WaveTec Vision to Commercialize Its Cataract Surgery Breakthrough April 16, 2012 | Press Release
Burrill & Company Leads ADMA Biologics’ $17.5 Million Private Placement April 15, 2012 | Press Release
See all News
BIO International Converntion: Burrill State-of-the-Industry Report
June 28, 2011Location: Walter E. Washington Convention Center, Room 146 ABC
Washington, D.C.
Biotech 2011-Life Sciences: Looking Back to See Ahead is Burrill's 25th anniversary annual report on the state of the biotech industry, highlighting the key global developments in 2010 including health care reform, comparative effectiveness, the specter of biogenerics and genetic patents under threat that could retard biotech innovation. The presentation will look back over 25 years and describe some of the critical events that have shaped the industry into the global enterprise it is today and discuss what companies will need to do in order to remain competitive in a world being influenced by a tougher financial climate, rapidly evolving technology, globalization and new emerging markets.
Website
back to Events list